Medika d.d. (ZSE: MDKA)
Croatia
· Delayed Price · Currency is HRK · Price in EUR
5,700.00
+50.00 (0.88%)
At close: Nov 20, 2024
Medika d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 811.07 | 750.49 | 628.1 | 4,130 | 3,990 | 3,647 | Upgrade
|
Revenue Growth (YoY) | 11.85% | 19.49% | -84.79% | 3.53% | 9.39% | 18.48% | Upgrade
|
Cost of Revenue | 746.12 | 690.85 | 577.1 | 3,788 | 3,671 | 3,339 | Upgrade
|
Gross Profit | 64.96 | 59.64 | 51 | 342.38 | 318.1 | 308.12 | Upgrade
|
Selling, General & Admin | 24.61 | 22.93 | 20.62 | 144.18 | 129.57 | 126.76 | Upgrade
|
Other Operating Expenses | 13.08 | 10.05 | 9.04 | 58.59 | 55.8 | 63.15 | Upgrade
|
Operating Expenses | 42.36 | 37.31 | 33.69 | 231.98 | 212.17 | 214.92 | Upgrade
|
Operating Income | 22.6 | 22.33 | 17.31 | 110.4 | 105.94 | 93.2 | Upgrade
|
Interest Expense | -1.94 | -1.73 | -0.37 | -4.46 | -6.93 | -6.68 | Upgrade
|
Interest & Investment Income | 2.82 | 2.28 | 2.65 | 10.49 | 1.73 | 2.07 | Upgrade
|
Earnings From Equity Investments | 0.51 | 0.43 | 0.43 | 2.84 | 2.3 | 1.95 | Upgrade
|
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.28 | 0.98 | -9.48 | -3.09 | Upgrade
|
EBT Excluding Unusual Items | 23.97 | 23.3 | 19.74 | 120.24 | 93.56 | 87.45 | Upgrade
|
Gain (Loss) on Sale of Assets | 1.08 | 1.08 | 0.9 | 0.61 | 0.23 | 2.99 | Upgrade
|
Legal Settlements | - | - | - | - | -0.02 | -0.42 | Upgrade
|
Pretax Income | 25.05 | 24.37 | 20.64 | 120.86 | 93.76 | 90.02 | Upgrade
|
Income Tax Expense | 4.82 | 4.29 | 5.15 | 21.35 | 16.89 | 17.24 | Upgrade
|
Net Income | 20.23 | 20.08 | 15.5 | 99.51 | 76.87 | 72.78 | Upgrade
|
Net Income to Common | 20.23 | 20.08 | 15.5 | 99.51 | 76.87 | 72.78 | Upgrade
|
Net Income Growth | 12.14% | 29.59% | -84.43% | 29.44% | 5.63% | 116.07% | Upgrade
|
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change (YoY) | - | - | 2.56% | 3.59% | - | -3.46% | Upgrade
|
EPS (Basic) | 698.83 | 693.51 | 535.16 | 3524.69 | 2820.65 | 2670.43 | Upgrade
|
EPS (Diluted) | 698.83 | 693.51 | 535.16 | 3524.69 | 2820.65 | 2670.43 | Upgrade
|
EPS Growth | 12.14% | 29.59% | -84.82% | 24.96% | 5.63% | 123.80% | Upgrade
|
Free Cash Flow | 12.9 | 18.13 | 7.33 | 269.65 | 98.34 | 4.83 | Upgrade
|
Free Cash Flow Per Share | 445.47 | 626.23 | 253.26 | 9551.15 | 3608.09 | 177.19 | Upgrade
|
Dividend Per Share | 200.000 | 200.000 | 215.000 | 1400.000 | 1400.000 | 1320.000 | Upgrade
|
Dividend Growth | -6.98% | -6.98% | -84.64% | 0% | 6.06% | 88.57% | Upgrade
|
Gross Margin | 8.01% | 7.95% | 8.12% | 8.29% | 7.97% | 8.45% | Upgrade
|
Operating Margin | 2.79% | 2.98% | 2.76% | 2.67% | 2.66% | 2.56% | Upgrade
|
Profit Margin | 2.49% | 2.68% | 2.47% | 2.41% | 1.93% | 2.00% | Upgrade
|
Free Cash Flow Margin | 1.59% | 2.42% | 1.17% | 6.53% | 2.46% | 0.13% | Upgrade
|
EBITDA | 25.13 | 24.53 | 19.36 | 124.93 | 119.3 | 105.98 | Upgrade
|
EBITDA Margin | 3.10% | 3.27% | 3.08% | 3.02% | 2.99% | 2.91% | Upgrade
|
D&A For EBITDA | 2.54 | 2.19 | 2.05 | 14.53 | 13.37 | 12.78 | Upgrade
|
EBIT | 22.6 | 22.33 | 17.31 | 110.4 | 105.94 | 93.2 | Upgrade
|
EBIT Margin | 2.79% | 2.98% | 2.76% | 2.67% | 2.66% | 2.56% | Upgrade
|
Effective Tax Rate | 19.22% | 17.62% | 24.93% | 17.66% | 18.01% | 19.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.